Frozen Shoulder in NYC: Why Adhesive Capsulitis Happens and How Regenerative Medicine Shortens Recovery
Frozen shoulder — known medically as adhesive capsulitis — is one of the most frustrating orthopedic conditions we treat at our New York City practice. It arrives without an obvious injury, steals range of motion month by month, and then lingers far longer than most patients are told it will. If you are searching for frozen shoulder treatment in NYC because you can no longer reach a seatbelt, fasten a bra, or sleep on your side, this guide explains what is actually happening inside the joint, what the evidence says about each treatment option, and where regenerative approaches such as PRP fit into a modern plan.
Dr. Ajit Dhaliwal treats shoulder pain at Regen Health Physicians in New York City and Salt Lake City, with an emphasis on non-surgical regenerative options for joint, back, and shoulder pain.
What Frozen Shoulder Actually Is
The shoulder is a ball-and-socket joint wrapped in a sleeve of connective tissue called the glenohumeral capsule. In a healthy shoulder that capsule is loose and redundant, which is precisely why the shoulder has more range of motion than any other joint in the body.
In adhesive capsulitis, that capsule becomes inflamed and then fibrotic. Biopsy and arthroscopic studies consistently show two features: dense type I and type III collagen deposition, and an abundance of myofibroblasts — contractile cells that behave much like the cells responsible for Dupuytren's contracture in the hand. Inflammatory cytokines including TNF-alpha, IL-1beta, and IL-6, along with elevated TGF-beta signaling, drive the transition from inflamed tissue to scarred, contracted tissue. The rotator interval and the coracohumeral ligament are typically the first structures to thicken.
This matters clinically for one reason: frozen shoulder is not a muscle problem, a "pinched nerve," or ordinary tendinitis. It is a fibrotic disease of the joint capsule. That is why stretching alone often fails, why cortisone timing matters enormously, and why treatments aimed at inflammation early in the disease work better than the same treatments applied late.
Primary vs. Secondary Adhesive Capsulitis
- Primary (idiopathic) frozen shoulder appears with no clear trigger. It most often affects adults between 40 and 60, and women somewhat more than men.
- Secondary frozen shoulder follows a triggering event: a rotator cuff tear, a proximal humerus fracture, breast or cardiac surgery, a prolonged period of immobilization in a sling, or a stroke.
Who Is at Highest Risk
Diabetes is the single strongest risk factor. Roughly 10 to 20 percent of people with diabetes develop adhesive capsulitis, compared with 2 to 5 percent of the general population, and diabetic frozen shoulder tends to be more severe and more resistant to treatment — likely because advanced glycation end products cross-link collagen and stiffen it. Thyroid disease (both hypo- and hyperthyroid), Parkinson's disease, and Dupuytren's contracture also raise risk. Because of this metabolic overlap, we frequently screen shoulder patients for undiagnosed insulin resistance and thyroid dysfunction as part of our chronic disease and metabolic evaluation.
The Three Stages — and Why Staging Changes Treatment
Frozen shoulder is classically described in three overlapping phases. Identifying which phase you are in is the most important decision point in the entire treatment plan.
Stage 1: Freezing (roughly 6 weeks to 9 months)
Pain dominates. It is often worse at night, poorly localized, and may radiate into the deltoid insertion. Range of motion is decreasing but the loss may still feel like guarding rather than a hard stop. This is the inflammatory phase, and it is the window in which anti-inflammatory intervention has the greatest effect on the total duration of the disease.
Stage 2: Frozen (roughly 4 to 12 months)
Pain begins to settle, but stiffness is now the defining problem. The hallmark exam finding is loss of passive external rotation with the arm at the side — meaning the shoulder will not rotate even when someone else moves it for you. That distinguishes frozen shoulder from a rotator cuff tear, where passive motion is usually preserved. Fibrosis is now established.
Stage 3: Thawing (roughly 12 to 42 months)
Motion returns gradually as the capsule remodels. The older teaching that every frozen shoulder fully resolves on its own has not held up: longer-term follow-up studies report that a meaningful minority of patients — commonly cited between 20 and 50 percent — retain some measurable motion deficit years later, though most are functionally comfortable.
The practical takeaway: the average untreated course runs 1 to 3 years. Treatment is not merely about comfort; it is about compressing that timeline and protecting the motion you keep.
Getting the Diagnosis Right
Frozen shoulder is a clinical diagnosis, but imaging matters for excluding mimics.
- Physical exam: the diagnostic signature is global restriction of both active and passive motion, with external rotation typically affected first and worst.
- X-ray: normal in true adhesive capsulitis. Its job is to rule out glenohumeral osteoarthritis, calcific tendinitis, and old fracture.
- MRI/MR arthrogram: may show thickening of the coracohumeral ligament and rotator interval and obliteration of the subcoracoid fat triangle. Most useful when a concurrent rotator cuff tear is suspected.
- Ultrasound: valuable in the office for dynamic assessment, for excluding cuff pathology, and for guiding injections accurately into the joint rather than the surrounding soft tissue.
- Labs: HbA1c, fasting insulin, and a thyroid panel are reasonable in anyone with primary frozen shoulder, because undiagnosed metabolic disease is common in this population.
Conditions that are frequently mistaken for frozen shoulder include rotator cuff tears, subacromial impingement, glenohumeral arthritis, cervical radiculopathy from the neck, and calcific tendinitis. A careful orthopedic evaluation sorts these out quickly.
Conventional Treatment: What the Evidence Supports
Physical Therapy
Therapy is foundational — but the type matters. Aggressive end-range stretching during the painful freezing stage can worsen inflammation and prolong the disease. Trials comparing intensive stretching with a gentler, pain-guided mobilization program have generally favored the gentler approach for early-stage patients. During the frozen stage, more assertive capsular stretching and joint mobilization become appropriate and productive.
Intra-Articular Corticosteroid Injection
This is the best-supported conventional intervention, and timing is everything. Systematic reviews show that ultrasound- or fluoroscopy-guided intra-articular steroid injections given during the freezing stage produce faster pain relief and faster motion recovery than therapy alone, with benefits typically most pronounced in the first 6 to 16 weeks. Injections given late, once fibrosis is mature, deliver far less. Repeated steroid injections carry real costs — cartilage and tendon effects with cumulative dosing, and transient blood glucose elevation that can be substantial in diabetics for several days.
Hydrodilatation (Capsular Distension)
Fluid — usually saline with an anesthetic and often a steroid — is injected under image guidance to stretch and, in some cases, rupture the contracted capsule. Evidence supports meaningful short- to medium-term improvement in pain and motion, and it is a reasonable next step when a steroid injection alone plateaus.
Manipulation Under Anesthesia and Arthroscopic Capsular Release
These are the escalation options for shoulders that remain severely restricted after 6 to 12 months of appropriate conservative care. Both are effective; both carry risk, including humeral fracture with manipulation and the usual surgical and anesthetic risks with release. Most patients never need them.
Where Regenerative Medicine Fits
Regenerative treatments are not a replacement for good staging, good therapy, or a well-timed steroid injection. They are a tool for a specific problem: modulating the inflammatory-to-fibrotic transition, and treating the shoulders that do not follow the textbook.
Platelet-Rich Plasma (PRP)
PRP is prepared from your own blood by concentrating platelets, which release growth factors including PDGF, TGF-beta, VEGF, and HGF. In adhesive capsulitis two mechanisms are relevant: modulation of the inflammatory cytokine environment, and hepatocyte growth factor's documented anti-fibrotic effect, which opposes the myofibroblast-driven scarring at the heart of the disease.
The clinical literature is early but encouraging. Several randomized comparisons of intra-articular PRP against corticosteroid in adhesive capsulitis have found comparable pain and function outcomes at 6 weeks with a trend favoring PRP at 12 weeks and beyond — a pattern consistent with steroid acting faster and PRP acting more durably. Sample sizes are modest and protocols vary, so we describe PRP to patients as promising and mechanistically sensible, not proven superior.
PRP is particularly worth discussing if you are diabetic and want to avoid the glucose spike of a steroid, if you have already had one or two steroid injections, or if there is coexisting rotator cuff tendinopathy that would benefit from the same injection. Our approach to PRP and regenerative joint care always uses ultrasound guidance — a blind glenohumeral injection misses the joint capsule a significant share of the time.
Peptide Support
Certain peptides are used adjunctively for connective tissue recovery and inflammatory modulation. The human clinical evidence base here is genuinely thin, and we say so directly to patients. When peptides are appropriate, they are prescribed as a supporting layer within a medically supervised peptide therapy program — never as a stand-alone treatment for a fibrotic capsule.
Metabolic and Hormonal Optimization
This is the most underused lever in frozen shoulder care. If HbA1c is 7.8 percent, the collagen in your capsule is being cross-linked by glycation faster than any injection can undo. Bringing glucose control, thyroid function, vitamin D, and sleep into range is not a wellness add-on — it changes the biology of the tissue you are trying to remodel. Patients with a metabolic driver typically do best when the shoulder plan and the metabolic plan run in parallel.
A Realistic Treatment Plan by Stage
Freezing stage (pain-dominant):
- Confirm the diagnosis clinically, with X-ray to exclude arthritis.
- Ultrasound-guided intra-articular injection — corticosteroid for fastest relief, or PRP if you are diabetic, steroid-averse, or already injected.
- Gentle, pain-guided range-of-motion work. Not aggressive stretching.
- Sleep positioning: supine with a pillow supporting the arm, or side-lying on the unaffected side hugging a pillow.
- Screen and treat metabolic contributors.
Frozen stage (stiffness-dominant):
- Escalate to structured capsular stretching and joint mobilization.
- Consider hydrodilatation if motion has plateaued.
- Consider PRP where there is concurrent cuff pathology or persistent inflammatory pain.
- Reassess objective motion every 4 to 6 weeks — measured degrees, not impressions.
Thawing stage:
- Progressive strengthening, especially of the rotator cuff and scapular stabilizers.
- Continue end-range work until motion is symmetric with the opposite side.
- Address the compensation patterns the neck and mid-back developed over the preceding year.
What Patients Ask Most
How long will this take? Untreated, 1 to 3 years. With early, well-timed intervention, most patients see substantial improvement within 3 to 6 months.
Will it come back? Recurrence in the same shoulder is uncommon. However, 6 to 17 percent of patients develop it in the opposite shoulder, usually within five years — one more reason to address underlying metabolic drivers.
Should I push through the pain? No. In the freezing stage, pain is a signal that you are provoking the inflammatory cycle. Motion work should stop at discomfort, not push past it.
Can I just wait it out? You can, and many people do. But waiting means 1 to 3 years of impaired sleep and function, and a meaningful chance of a permanent motion deficit. Early intervention is the better trade.
Does insurance cover PRP? Generally not. We discuss cost transparently before any procedure, and we will tell you plainly when a covered option is likely to serve you just as well.
When to Be Seen
Get evaluated if you have shoulder pain with progressive stiffness for more than four weeks, if you cannot rotate your arm outward with your elbow at your side, if night pain is disrupting sleep, or if you have diabetes and new shoulder pain. Earlier evaluation means catching the freezing stage while it is still responsive.
To have your shoulder evaluated by Dr. Dhaliwal in New York City or Salt Lake City, book a consultation. You can also read more about our approach and philosophy or browse other articles on the RHPNY blog.
---
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Regenerative therapies including PRP are not FDA-approved for the treatment of adhesive capsulitis, and individual results vary. Always consult a qualified physician regarding your specific condition before beginning any treatment.
